Wenemea
Aarhus
About Wenemea
Wenemea is the developer of chemotherapy-induced peripheral neuropathy designed for cancer treatment through neurological screening.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $1.1M
- Last round: Grant (Jan 2026)
- Website: wenemea.com
- Phone: [email protected]
Industries & Categories
Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/wenemea-102552 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.